1. Home
  2. RHI vs TXG Comparison

RHI vs TXG Comparison

Compare RHI & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robert Half Inc.

RHI

Robert Half Inc.

HOLD

Current Price

$27.26

Market Cap

2.8B

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$20.49

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RHI
TXG
Founded
1948
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RHI
TXG
Price
$27.26
$20.49
Analyst Decision
Hold
Hold
Analyst Count
6
14
Target Price
$36.00
$16.18
AVG Volume (30 Days)
2.3M
2.6M
Earning Date
01-29-2026
02-12-2026
Dividend Yield
8.71%
N/A
EPS Growth
N/A
N/A
EPS
1.33
N/A
Revenue
$5,378,506,000.00
$641,814,000.00
Revenue This Year
N/A
$4.94
Revenue Next Year
$0.76
N/A
P/E Ratio
$20.39
N/A
Revenue Growth
N/A
1.92
52 Week Low
$25.22
$6.78
52 Week High
$70.35
$23.56

Technical Indicators

Market Signals
Indicator
RHI
TXG
Relative Strength Index (RSI) 45.04 53.90
Support Level $26.76 $19.34
Resistance Level $29.31 $23.56
Average True Range (ATR) 1.08 1.35
MACD -0.14 -0.12
Stochastic Oscillator 23.88 42.29

Price Performance

Historical Comparison
RHI
TXG

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: